ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

TALS Talaris Therapeutics Inc

2.72
0.00 (0.00%)
Last Updated: 20:00:00
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 2.63
Ask Price 2.78
News -
Day High

Low
20.00

52 Week Range

High
32.90

Day Low
Company Name Stock Ticker Symbol Market Type
Talaris Therapeutics Inc TALS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 2.72 20:00:00
Open Price Low Price High Price Close Price Prev Close
2.72
Trades Volume Avg Volume 52 Week Range
0 0 - 20.00 - 32.90
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 2.72 USD

Talaris Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 116.32M - - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Talaris Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No TALS Message Board. Create One! See More Posts on TALS Message Board See More Message Board Posts

Historical TALS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months31.0031.3026.0028.02310,320-28.28-91.23%
1 Year21.4032.9020.0027.99400,836-18.68-87.29%
3 Years172.50198.208.9044.39212,301-169.78-98.42%
5 Years172.50198.208.9044.39212,301-169.78-98.42%

Talaris Therapeutics Description

Talaris Therapeutics Inc is a late-clinical stage biotechnology company. It is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe autoimmune and immune-mediated disorders.

Your Recent History

Delayed Upgrade Clock